Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Hubei Xingfa Chemicals Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Hubei Xingfa Chemicals Group şirketinin toplam hissedar öz sermayesi CN¥22.0B ve toplam borcu CN¥13.5B olup, bu da borç-öz sermaye oranını 61.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥45.4B ve CN¥23.3B dir. Hubei Xingfa Chemicals Group 'in FAVÖK'ü CN¥2.3B faiz karşılama oranı 9 dur. Şirketin CN¥2.1B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

61.3%

Borç/özkaynak oranı

CN¥13.51b

Borç

Faiz karşılama oranı	9x
Nakit	CN¥2.07b
Eşitlik	CN¥22.05b
Toplam yükümlülükler	CN¥23.32b
Toplam varlıklar	CN¥45.37b

Son finansal sağlık güncellemeleri

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Jun 11

Recent updates

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Sep 09

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Jul 17

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Jun 11

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

May 21

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

Apr 05

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 600141 'nin kısa vadeli varlıkları ( CN¥7.6B ) kısa vadeli yükümlülüklerini ( CN¥11.9B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 600141 'un kısa vadeli varlıkları ( CN¥7.6B ) uzun vadeli yükümlülüklerini ( CN¥11.4B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 600141 'nin net borç/öz sermaye oranı ( 51.9% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 600141 'nin borç/öz sermaye oranı son 5 yılda 155.3% seviyesinden 61.3% seviyesine düştü.

Borç Kapsamı: 600141 'nin borcu işletme nakit akışı ( 11% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 600141 'in borcuna ilişkin faiz ödemeleri EBIT ( 9 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Hubei Xingfa Chemicals Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Recent updates

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.15 in 2Q 2023)

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Dividend of CN¥0.60 announced

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

First quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.40 in 1Q 2023)

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

New major risk - Financial position

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 16%

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

Hubei Xingfa Chemicals' Controlling Shareholder Plans to Raise its Holdings in the Company

Consensus EPS estimates fall by 43%

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

New minor risk - Profit margin trend

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q2, 2023 Results on Aug 21, 2023

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Price target decreased to CN¥45.75

Third quarter 2022 earnings released: EPS: CN¥1.17 (vs CN¥1.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.70 in 2Q 2021)

Price target increased to CN¥51.33

Investor sentiment deteriorated over the past week

Price target increased to CN¥49.56

Investor sentiment improved over the past week

Price target increased to CN¥45.41

Investor sentiment improved over the past week

Consensus EPS estimates increase by 14%

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Price target increased to CN¥44.89

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.10 (vs CN¥0.22 in 3Q 2020)

Investor sentiment deteriorated over the past week

Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) signed an Equity Purchase Agreement to acquire additional 18.785% minority stake in Hubei Taisheng Chemical Co., Ltd. from ABC Financial Asset Investment Co., Ltd. for approximately CNY 510 million.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Consensus EPS estimates increase to CN¥1.66

Second quarter 2021 earnings released: EPS CN¥0.70 (vs CN¥0.14 in 2Q 2020)

Consensus forecasts updated

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.02 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.33 in FY 2019)

New 90-day high: CN¥14.78

New 90-day high: CN¥13.77

New 90-day high: CN¥12.40

Third quarter earnings released

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020

Analysts lower EPS estimates to CN¥0.35

Earnings released

New 90-day high - CN¥11.85

New 90-day high - CN¥10.59

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin